Release Date: 16/09/19 12:59 Summary: Partly Paid Shares - Call Notice Price Sensitive: No Download Document 2MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%